Long-Term Safety, Tolerability, and Efficacy of DTX101 (AAVrh10FIX) in Adults With Moderate/Severe to Severe Hemophilia B

Long-Term Safety and Efficacy of rFIXFc in the Prevention and Treatment of Bleeding Episodes in Previously Treated Participants With Hemophilia B

NCT01425723 ·Status: COMPLETED ·Phase: PHASE3

Gene Therapy Study in Severe Haemophilia A Patients (270-201)

NCT02576795 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Safety and Efficacy Extension Study of a Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Patients With Hemophilia B

NCT02053792 ·Status: COMPLETED ·Phase: PHASE3

BAX 855 Continuation

NCT01945593 ·Status: COMPLETED ·Phase: PHASE3

Safety of a New Type of Treatment Called Gene Transfer for the Treatment of Severe Hemophilia B

NCT00076557 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

A Safety, Tolerability, and Pharmacokinetics Study of a Single Intravenous Injection of Recombinant Coagulation Factor VIII Fc - Von Willebrand Factor - XTEN Fusion Protein (rFVIIIFc-VWF-XTEN) (BIVV001) in Previously Treated Adults With Severe Hemophilia A (EXTEN-A)

NCT03205163 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

2-cohort Study of Adult Patients With Severe Hemophilia A in Greece

NCT02319070 ·Status: COMPLETED

Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis

NCT05022459 ·Status: RECRUITING

Trial of AAV5-hFIX in Severe or Moderately Severe Hemophilia B

NCT02396342 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B

NCT06379789 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Study to Test the Safety of an Investigational Drug Given Repeatedly to Adult Men With Severe Hemophilia

NCT03996486 ·Status: WITHDRAWN ·Phase: PHASE1

A Study of PEGylated Recombinant Factor VIII (BAX855) in Previously Untreated Young Children With Severe Hemophilia A

NCT02615691 ·Status: COMPLETED ·Phase: PHASE3

A Safety, Efficacy and Pharmacokinetics Study of a Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Children With Hemophilia B

NCT01662531 ·Status: COMPLETED ·Phase: PHASE3

Covalent Tolerance Induction to Factor VIII-Prediction of Inhibitors in Hemophilia

NCT00178607 ·Status: COMPLETED

Personalized Prediction of Tolerance and Immunogenicity in Hemophilia

NCT01626105 ·Status: UNKNOWN

Evaluation of the Safety and Efficacy of Hemophilia B Gene Therapy Drug

NCT05203679 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3

Study Evaluating rFIX; BeneFIX® in Hemophilia B

NCT00093171 ·Status: COMPLETED ·Phase: PHASE3

Dose-Escalation Study Of A Self Complementary Adeno-Associated Viral Vector For Gene Transfer in Hemophilia B

NCT00979238 ·Status: COMPLETED ·Phase: PHASE1

Evaluate Efficacy and Safety of Recombinant Factor VIII （rFVIII）Treatment of Severe or Moderately Severe Hemophilia A

NCT02930317 ·Status: UNKNOWN ·Phase: PHASE3

ATHN 7: Hemophilia Natural History Study

NCT03619863 ·Status: COMPLETED

ATHN 11: Liver Transplantation Outcomes Study

NCT04055051 ·Status: COMPLETED

Study of Recombinant Factor IX Product, IB1001, in Subjects With Hemophilia B

NCT00768287 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Trial of Rituximab Versus Oral Cyclophosphamide to Eradicate or Suppress Autoimmune Anti-Factor VIII Antibodies in Acquired Hemophilia A

NCT00306670 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

BeCoMe-9: A Clinical Study of BE-101 for the Treatment of Adults With Moderately Severe or Severe Hemophilia B

NCT06611436 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Clinical Study of Recombinant Human Coagulation Factor VIII for Injection in Patients With Severe Hemophilia A

NCT06297655 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3